Use of bisphosphonates in the prevention of bone loss and fractures

The American Journal of Medicine

Volumn 91, Issue 5 SUPPL. 2, 1991, Pages

  Parfitt, A Michael ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PAMIDRONIC ACID;

ADULT; BONE ATROPHY; CONFERENCE PAPER; FEMALE; FRACTURE; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL;

BONE DENSITY; CLINICAL TRIALS; DIPHOSPHONATES; FRACTURES; HUMAN; OSTEOPOROSIS;

EID: 0026323065     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(91)90246-T     Document Type: Article

References (27)

1. Bisphosphonates—history and experimental basis
2. The use of bisphosphonate in osteoporosis
3. A brief history of etidronate
4. Technetium-99m-pyrophosphate: studies in vivo and in vitro
5. The three organizational levels of bone remodeling—implications for the interpretation of biochemical markers and the mechanisms of bone loss
6. The composition, structure and remodeling of bone: a basis for the interpretation of bone mineral measurements
7. ADFR, or coherence therapy, for osteoporosis
8. Prevention of postmenopausal bone loss by tiludronate
9. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxyroprylidene)-1,1-bisphosphonate (APD)
10. Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humans
11. Effects of clodronate on immobilization bone loss
12. Synthetic salmon calcitonin, diphosphonates and anabolic steroids in the treatment of postmenopausal osteoporosis
13. Bisphosphonates therapy with APD in involutional osteoporosis with vertebral crush fractures
14. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD
15. Treatment of involutional osteoporosis with the bisphosphonate APD (disodium pamidronate) non-linear increase of lumbar bone mineral density
16. New bisphosphonates in the treatment of osteoporosis
17. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
18. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
19. Radiographic assessment of the effects of intermittent cyclical treatment with etidronate
20. The progression of spinal osteoporosis can be monitored by serial measurement of stature
21. A new option for treating osteoporosis
22. Bone histomorphometric changes in women with postmenopausal osteoporosis treated with etidronate
23. Reduction in fracture rate after intermittent etidronate: Histomorphometric evidence of mechanism
24. Histomorphometric findings after cyclical etidronate treatment: Histopathogenic bases of clinical results
25. Variations in strength of vertebrae with age and their relation to osteoporosis
26. Age-related changes in vertebral trabecular bone architecture—assessed by a new method
27. Etidronate for postmenopausal osteoporosis